SCHEMBL4906970

SCHEMBL4906970

Cc1cc(S(=O)(=O)NCCc2ccc3sc(-c4ccccc4)nc3c2)cc(C(=O)O)c1C

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NFKB1 P19838 4/20 0.49
NFKB2 Q00653 4/20 0.49
RELA Q04206 4/20 0.49
NPC1 O15118 3/20 0.49
RAB9A P51151 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
PKM P14618 2/20 0.49
HPGD P15428 2/20 0.49
KDM4E B2RXH2 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
STAT1 P42224 1/20 0.47
LMNA P02545 4/20 0.43
TP53 P04637 2/20 0.43
THRB P10828 1/20 0.43
ILK Q13418 2/20 0.43
MAPT P10636 1/20 0.43
AKR1C3 P42330 4/20 0.42
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4904070 0.92 NPC1 (0.52) NFKB1NFKB2RELANPC1RAB9A
SCHEMBL4902822 0.90 LMNA (0.52) NFKB1NFKB2RELANPC1RAB9A
SCHEMBL4894576 0.85 NPC1 (0.49) NFKB1NFKB2RELANPC1RAB9A
SCHEMBL4895876 0.85 NPC1 (0.53) NFKB1NFKB2RELANPC1RAB9A
SCHEMBL4902516 0.85 NPC1 (0.48) NFKB1NFKB2RELANPC1RAB9A
SCHEMBL4903797 0.83 LMNA (0.46) LMNATP53THRBMAPTAKR1C3
SCHEMBL4909037 0.82 PTPN5 (0.48) NPC1RAB9ASMN1; SMN2HPGDKDM4E
SCHEMBL4904176 0.80 NPC1 (0.52) NFKB1NFKB2RELANPC1RAB9A
SCHEMBL4905795 0.80 NPC1 (0.52) NFKB1NFKB2RELANPC1RAB9A
SCHEMBL4903641 0.77 MAPT (0.42) LMNATP53THRBMAPTAKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD NFKB1 1696/4885NFKB2 2174/4885RELA 1097/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD NFKB1 1853/4885NFKB2 2288/4885RELA 1074/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD NFKB1 1853/4885NFKB2 2288/4885RELA 1074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.